Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0000899243-20-027688

Director acquired 711,447 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Prokupets Elena Director 2020-10-06 Conversion +118,574 118,574 I
Prokupets Elena Director 2020-10-06 Conversion +592,873 592,873 I
Derivatives
Prokupets Elena Director 2020-10-06 Conversion · Series A Preferred Stock −1,000,000 0 I
Prokupets Elena Director 2020-10-06 Conversion · Series A Preferred Stock −5,000,000 0 I
Loading xslF345X03/doc4.xml…